<DOC>
	<DOCNO>NCT02500836</DOCNO>
	<brief_summary>Randomized , prospective , multi-center , double blind placebo-controlled parallel group study Placebo Topical Solution versus Cocaine HCl 4 % Topical Solution safety efficacy , Cocaine HCl 4 % 10 % Topical Solution Safety anesthetic prior diagnostic procedure surgery accessible mucous membrane nasal cavity . Both domestic ( United States ) foreign site eligible , inpatient outpatient setting eligible .</brief_summary>
	<brief_title>Topical Application Cocaine HCl 4 % , 10 % , Placebo Solution Local ( Topical ) Anesthesia</brief_title>
	<detailed_description>Eligible subject undergo either office-based operating room-based procedure surgery . The approximately 620 subject randomize 2:2:1 fashion one three treatment group ( 248 subject randomize Cocaine HCl 4 % solution , 248 subject randomize Cocaine HCl 10 % , 124 subject randomize placebo solution ) pre-procedure give one application assign test product Von Frey filament test occur application .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Subjects must meet following criterion prior enrollment study : Provide write informed consent HIPAA authorization . Residents California must also review sign California Subject Bill Rights . Male female â‰¥18 year age . Predetermined need physician diagnostic procedure surgery nasal mucous membrane either one two nostril merit use anesthesia . Ability feel pain sensation normally nasal mucous membrane , verify via Von Frey 5.88 monofilament test Ability clearly communicate pain sensation nasal mucous membrane . Has know allergy ester base anesthetic include cocaine , procaine , tetracaine , chlorprocaine , dibucaine , benzocaine and/or compound drug and/or device part protocol . ( Amide base nonester base anesthetic allergy NOT exclusionary . Amide base anesthetic : Lidocaine , Mepivicaine , Bupivicaine , Levobupivicaine , Ropivicaine , Etidocaine , Prolicaine , Articaine ) . Has history abuse control substance , nasal otherwise , damage nasal space , opinion investigator might interfere ability subject investigator judge anesthesia trial drug . Has use investigational drug ( ) within 30 day precede randomization . Is pregnant nurse mother Women childbearing potential ( WOCBP ) male partner WOCBP willing use acceptable method contraception avoid pregnancy throughout study . Contraceptive practice must extend woman least 30 day male partner WOCBP least 90 day last dose investigational product manner risk pregnancy risk pregnancy minimize . Is &lt; 18 year age Suffers condition , need diagnostic procedure surgery nasal mucous membrane , opinion Investigator , would compromise safety subject , quality data , normal wound heal process . Use analgesic 2 day prior screen need use drug screen period . This include NSAIDs , ibuprofen , diclofenac , indomethacin , sulindac , tolmetin , ketoprofen , flurbiprofen , naproxen , opioids codeine , hydrocodone , hydromorphone , morphine , oxycodone , aspirin , acetaminophen . Subjects experienced seizure take isoniazid ( INH ) , phenothiazine , chlorpromazine , thioridazine , theophylline , tricyclic antidepressant amitriptyline . Has previously receive study drug study . Subjects fail screening may rescreen eligibility requirement meet , subject receive study drug study . Has history myocardial infarction , coronary artery disease , congestive heart failure , irregular heart rhythm ( fully define section 7.9.4 , 7.9.5 7.9.6 ) uncontrolled hypertension take monoamine oxidase inhibitor ( 6 ) . Uncontrolled hypertension define systolic blood pressure great equal 140 mm Hg diastolic blood pressure great equal 90 mm Hg ( 43 ) ( 44 ) . Has know personal family history hereditary pseudocholinesterase deficiency . ( 2 ) Study participant screen ask personal family history anesthetic reaction , anesthetic death , previous diagnosis pseudocholinesterase deficiency relative personally . Subjects identify pseudocholinesterase deficiency risk delay recovery certain anesthetic ( e.g . succinylcholine esterbased anesthetic ) . ( 14 ) Has know personal family history pheochromocytoma . ( 2 ) Study participant specifically ask treated pheochromocytoma previously family member diagnose pheochromocytoma ( since 10 % familial ) . ( 14 ) Has know personal family history adrenal tumor . Use amphetamines 2 day prior screen need use drug course study . All stimulant prescription , nonprescription product catecholamine ( norepinephrine epinephrine ) , ephedrine , pseudoephedrine amphetamine 48 hour prior screen need use drug course study . All herbal product except coffee , tea , herbal tea also prohibit within 48 hour prior screen subject need use drug course study . Coffee , Tea , Herbal Tea exclusionary criterion prohibit medication food product prescription nonprescription product . Has screen 12lead ECG finding abnormality list section 7.9.4 , 7.9.5 , 7.9.6 . Generally , current prior myocardial ischemia infarction , dysrhythmia , risk serious dysrhythmia ( prolonged QT interval ) include clinically significant abnormal ECG finding , opinion Investigator consultation Medical Monitor , may potentially result trial unsafe subject . An exception would 7.9.5.11 ( rest sinus bradycardia rest sinus tachycardia limit 110 beat per minute ) represent normal variant may find young old healthy adult . ( 36 ) Hemoglobin &lt; 8.5 g/dL ; onetime retest allow Hb 8.3 8.4 g/dL WBC &lt; 3.5 x 103 cells/mcL ; onetime retest allow WBC 3.33.4 x 103 cells/mcL Platelets &lt; 100 x 103 platelets/mcL ; onetime retest allow platelet 9099x 103 platelets/mcL Serum Potassium &lt; 3.5 &gt; 5.0 mEq/L Serum ALT , AST , bilirubin exceed 2X ULN lab 's reference value Cardiac enzymes range normal Coagulation study opinion investigator would cause subject exclude study . Positive urine pregnancy test screen Day 1 Positive urine drug test screen Day 1 without prior medicallynecessary use control substance ( example , benzodiazepine anxiety ) Subjects member Investigational Team , include Investigators SubInvestigators , immediate family . A onetime retest permit blood test original sample hemolyzed .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Ear</keyword>
	<keyword>Nose</keyword>
	<keyword>Throat</keyword>
</DOC>